CARSON DOTY: Open Payments
NPI 1215543467 · TOMBALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 49 payments from 11 companies in 2025. Trend: 2023 $1,091 · 2024 $903 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $225 |
| AstraZeneca Pharmaceuticals LP | 6 | $216 |
| Exact Sciences Corporation | 9 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Edwards Lifesciences Corporation | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
Products named: Cologuard Collection Kit, VRAYLAR, BREZTRI, Kerendia, JARDIANCE, AIRSUPRA, UBRELVY, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
